Who Supplies Moxifloxacin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Moxifloxacin exports, with 336+ registered manufacturers shipping to buyers across 137+ countries — yet a handful of companies dominate the shipments. MACLEODS PHARMACEUTICALS LTD holds the largest share at 43.7% (export value: $14.3M). Close behind, MSN LABORATORIES PRIVATE LIMITED (4.8%, $1.6M). EUGIA PHARMA SPECIALITIES LIMITED (3.9%, $1.3M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Moxifloxacin? Top Manufacturers & Their Buyers
Flow of Moxifloxacin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Moxifloxacin Supplier Network — Key Market Intelligence
The Moxifloxacin export market from India is led by MACLEODS PHARMACEUTICALS LTD, which alone commands a 43.7% share, shipping $14.3M worth of product across 27 shipments. The second-largest exporter, MSN LABORATORIES PRIVATE LIMITED, contributes $1.6M (4.8%) to the overall market. Combined, the top two suppliers alone account for 48.5% of all Moxifloxacin exports, indicating a relatively concentrated supply base.
Across all 336 tracked manufacturers, the total Moxifloxacin export value stands at $32.8M from 2.4K shipments. The market average shipment value is $13.6K. The single largest buyer relationship in terms of trade value is NATIONAL TUBERCULOSIS AND LEPROSY, receiving $13.8M worth of product.
The combined buyer network spans 23 named purchasing companies, including NATIONAL TUBERCULOSIS AND LEPROSY, I+ SOLUTIONS,, DEPARTMENT OF HEALTH, BRANCH CO MACLEODS P, MACLEODS PHARMACEUTI and 18 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the first-largest Moxifloxacin exporter from India, with a market share of 43.7% and a total export value of $14.3M across 27 shipments. Their average shipment value of $531.3K is above the market average of $13.6K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. NATIONAL TUBERCULOSIS AND LEPROSY is the dominant customer, accounting for 96.4% of this supplier's tracked business. Top customers include:
• NATIONAL TUBERCULOSIS AND LEPROSY — $13.8M across 26 shipments (96.4% of this supplier's total exports)
• I+ SOLUTIONS, — $199.8K across 0 shipments (1.4% of this supplier's total exports)
• DEPARTMENT OF HEALTH — $191.6K across 0 shipments (1.3% of this supplier's total exports)
• BRANCH CO MACLEODS P — $83.6K across 0 shipments (0.6% of this supplier's total exports)
• MACLEODS PHARMACEUTI — $34.3K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $531.3K is 3807% above the market average of $13.6K, consistent with large-order contracts or value-added formulations.
2MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the second-largest Moxifloxacin exporter from India, with a market share of 4.8% and a total export value of $1.6M across 89 shipments. Their average shipment value of $17.7K is above the market average of $13.6K, suggesting premium or bulk contract pricing.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• I+ SOLUTIONS, — $485.2K across 27 shipments (30.7% of this supplier's total exports)
• TO THE ORDER OF — $466.4K across 26 shipments (29.5% of this supplier's total exports)
• NOVADOZ PHARMACEUTICALS LLC — $249.6K across 14 shipments (15.8% of this supplier's total exports)
• I+ SOLUTIONS, — $245.9K across 14 shipments (15.6% of this supplier's total exports)
• I SOLUTIONS POLARNER — $132.0K across 7 shipments (8.4% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $17.7K is 30% above the market average of $13.6K, consistent with large-order contracts or value-added formulations.
3EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the third-largest Moxifloxacin exporter from India, with a market share of 3.9% and a total export value of $1.3M across 39 shipments. Their average shipment value of $32.9K is above the market average of $13.6K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NORTHSTAR DISTRIBUTION CENTER 8912 — $511.0K across 16 shipments (39.9% of this supplier's total exports)
• AUROBINDO PHARMA USA., INC, — $442.3K across 13 shipments (34.5% of this supplier's total exports)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $125.7K across 4 shipments (9.8% of this supplier's total exports)
• AUROBINDO PHARMA USA., INC, — $107.3K across 3 shipments (8.4% of this supplier's total exports)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $94.9K across 3 shipments (7.4% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $32.9K is 142% above the market average of $13.6K, consistent with large-order contracts or value-added formulations.
4MICRO LABS LIMITED
MICRO LABS LIMITED is the fourth-largest Moxifloxacin exporter from India, with a market share of 3.2% and a total export value of $1.1M across 86 shipments. Their average shipment value of $12.3K is below the market average of $13.6K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MICRO NOVA PHARMACEUTICALS IND — $282.7K across 23 shipments (26.7% of this supplier's total exports)
• MAXIM INTER-CORPORATION LTD. — $215.1K across 17 shipments (20.3% of this supplier's total exports)
• MSK PHARMALOGISTIC G — $214.7K across 17 shipments (20.3% of this supplier's total exports)
• MAXIM INTER-CORPORATION LTD. — $186.1K across 15 shipments (17.6% of this supplier's total exports)
• MICROSYNERGY PHARMAC — $160.4K across 13 shipments (15.2% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (86 shipments) at a per-shipment value of $12.3K, indicating a broad distribution network with many smaller, regular orders.
5MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fifth-largest Moxifloxacin exporter from India, with a market share of 2.9% and a total export value of $960.4K across 28 shipments. Their average shipment value of $34.3K is above the market average of $13.6K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN INSTITUTIONAL INC 2898 is the dominant customer, accounting for 77.3% of this supplier's tracked business. Top customers include:
• MYLAN INSTITUTIONAL INC 2898 — $742.1K across 22 shipments (77.3% of this supplier's total exports)
• CSP VIATRIS SANTE AT — $117.1K across 3 shipments (12.2% of this supplier's total exports)
• M/S..MYLAN INSTITUTI — $44.7K across 1 shipments (4.7% of this supplier's total exports)
• MYLAN INSTITUTIONAL INC 2898 — $44.6K across 1 shipments (4.6% of this supplier's total exports)
• VIATRIS PHARMACEUTIC — $11.9K across 0 shipments (1.2% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $34.3K is 152% above the market average of $13.6K, consistent with large-order contracts or value-added formulations.
6AJANTA PHARMA LIMITED
AJANTA PHARMA LIMITED is the fifth-largest Moxifloxacin exporter from India, with a market share of 2.7% and a total export value of $899.0K across 112 shipments. Their average shipment value of $8.0K is below the market average of $13.6K, reflecting a high-volume, competitive pricing strategy.
AJANTA PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• PLANET PHARMA SA — $341.8K across 43 shipments (38.0% of this supplier's total exports)
• HAWKARY PHARMACEUITCAL CO.* — $212.7K across 27 shipments (23.7% of this supplier's total exports)
• HARLEYS LIMITED — $123.0K across 15 shipments (13.7% of this supplier's total exports)
• BRANCH OFFICE AJANTA — $119.2K across 15 shipments (13.3% of this supplier's total exports)
• KAWKAB SCIENTIFIC BU — $102.3K across 13 shipments (11.4% of this supplier's total exports)
Key Insight: AJANTA PHARMA LIMITED operates with high shipment frequency (112 shipments) at a per-shipment value of $8.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Moxifloxacin Flows
Once Moxifloxacin leaves the manufacturing plants of companies like MACLEODS PHARMACEUTICALS LTD and MSN LABORATORIES PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $32.8M. Nigeria absorbs the largest share at 44.8% ($14.7M), followed by United States (17.5%) and Netherlands (5.1%).
In Nigeria — the top destination — named importers include NATIONAL TUBERCULOSIS AND LEPROSY, MICRO NOVA PHARMACEUTICALS IND. In United States, key buyers are AUROLOGISTICS LLC, (AUROBINDO PHARM, MYLAN INSTITUTIONAL INC 2898, NORTHSTAR DISTRIBUTION CENTER 8912.
This geographic spread reflects Moxifloxacin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Moxifloxacin Go? Top Importing Countries & Their Buyers
Trade flow of Moxifloxacin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Nigeria
Nigeria ranks as the first-largest destination for Moxifloxacin imports from India, with a total trade value of $14.7M across 8 shipments — representing a 44.8% share of all Moxifloxacin exports. The average shipment value of $1.8M is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Moxifloxacin importers in Nigeria: NATIONAL TUBERCULOSIS AND LEPROSY is the largest buyer, accounting for 94.2% ($13.8M) of this market's total imports.
• NATIONAL TUBERCULOSIS AND LEPROSY — $13.8M (94.2% of Nigeria's total)
• MICRO NOVA PHARMACEUTICALS IND — $383.9K (2.6% of Nigeria's total)
Key Insight: Nigeria's per-shipment average of $1.8M (13402% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Moxifloxacin imports from India.
2United States
United States ranks as the second-largest destination for Moxifloxacin imports from India, with a total trade value of $5.8M across 82 shipments — representing a 17.5% share of all Moxifloxacin exports. The average shipment value of $70.2K is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.
Named Moxifloxacin importers in United States: AUROLOGISTICS LLC, (AUROBINDO PHARM is the largest buyer, accounting for 12.9% ($744.3K) of this market's total imports.
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $744.3K (12.9% of United States's total)
• MYLAN INSTITUTIONAL INC 2898 — $742.1K (12.9% of United States's total)
• NORTHSTAR DISTRIBUTION CENTER 8912 — $569.4K (9.9% of United States's total)
Key Insight: United States's per-shipment average of $70.2K (416% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Moxifloxacin imports from India.
3Netherlands
Netherlands ranks as the third-largest destination for Moxifloxacin imports from India, with a total trade value of $1.7M across 16 shipments — representing a 5.1% share of all Moxifloxacin exports. The average shipment value of $104.9K is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Moxifloxacin importers in Netherlands: I+ SOLUTIONS, is the largest buyer, accounting for 28.9% ($485.2K) of this market's total imports.
• I+ SOLUTIONS, — $485.2K (28.9% of Netherlands's total)
• I+SOLUTIONS — $383.6K (22.9% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $104.9K (671% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Moxifloxacin imports from India.
4Thailand
Thailand ranks as the fourth-largest destination for Moxifloxacin imports from India, with a total trade value of $1.0M across 12 shipments — representing a 3.2% share of all Moxifloxacin exports. The average shipment value of $86.3K is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Moxifloxacin importers in Thailand: MAXIM INTER-CORPORATION LTD is the largest buyer, accounting for 35.4% ($366.4K) of this market's total imports.
• MAXIM INTER-CORPORATION LTD — $366.4K (35.4% of Thailand's total)
• MAXIM INTER-CORPORATION LTD. — $295.5K (28.5% of Thailand's total)
Key Insight: Thailand's per-shipment average of $86.3K (535% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Moxifloxacin imports from India.
5France
France ranks as the fifth-largest destination for Moxifloxacin imports from India, with a total trade value of $737.5K across 12 shipments — representing a 2.2% share of all Moxifloxacin exports. The average shipment value of $61.5K is above the global average of $13.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Moxifloxacin importers in France: PLANET PHARMA SA is the largest buyer, accounting for 46.3% ($341.8K) of this market's total imports.
• PLANET PHARMA SA — $341.8K (46.3% of France's total)
Key Insight: France's per-shipment average of $61.5K (352% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Moxifloxacin imports from India.
People Also Ask — Moxifloxacin Supplier & Trade Network
Who are the top suppliers of Moxifloxacin from India?+
Which companies buy Moxifloxacin from Indian manufacturers?+
Where does Moxifloxacin exported from India go?+
What is the market share of the top Moxifloxacin supplier from India?+
What is the average shipment value for Moxifloxacin exports from India?+
Is Moxifloxacin manufactured in India and exported globally?+
Which country imports the most Moxifloxacin from India?+
Who are the buyers of Moxifloxacin in United States?+
How concentrated is the Moxifloxacin supplier market in India?+
How do I find verified buyers for Moxifloxacin in specific countries?+
Moxifloxacin Trade Network — Key Takeaways
- 1MACLEODS PHARMACEUTICALS LTD is India's dominant Moxifloxacin exporter with a 43.7% market share and $14.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 336 suppliers collectively account for 61.3% of all tracked Moxifloxacin exports, with a combined trade value of $32.8M.
- 3Nigeria is the largest destination market, absorbing 44.8% of India's Moxifloxacin exports ($14.7M). United States (17.5%) and Netherlands (5.1%) follow.
- 4With 2.4K total shipments averaging $13.6K each, the Moxifloxacin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include NATIONAL TUBERCULOSIS AND LEPROSY, I+ SOLUTIONS,, I+ SOLUTIONS,, NOVADOZ PHARMACEUTICALS LLC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 137 countries
Network value: $32.8M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Moxifloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Moxifloxacin.
- 2.Flow Mapping: 336 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,413 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 137 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,413 Verified Shipments
336 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists